CIRM Funded Clinical Trials

A Phase 2b Study of the Efficacy of a Novel Pro-Neurogenesis/Pro-Plasticity Drug for Bipolar Depression Using a Precision Psychiatry Approach

Disease Area:
Neurological Disorders
Investigator:
Institution:
CIRM Grant:
CLIN2-15395 (Closed)
Award Value:
$0.00
Trial Sponsor:
Alto Neuroscience
Trial Stage:
Phase 2
Trial Status:
Launching
Targeted Enrollment:
N/A

CIRM Clinical Trial Resources


Patient Stories of Hope

CIRM Alpha Stem Cell Clinics

Patient Toolbox


Video on Stem Cell Trials


Other Resources

ISSCR Patient Website

ClinicalTrials.gov